Priorities for efficacy trials of gender-affirming hormone therapy with estrogen: collaborative design and results of a community survey

By sjmartinez • February 5, 2024

Grock S, Weinreb J, Williams KC, Weimer A, Fadich S, Patel R, Geft A, Korenman S. Priorities for efficacy trials of gender-affirming hormone therapy with estrogen: collaborative design and results of a community survey. Hormones (Athens). 2024 Feb 5. doi: 10.1007/s42000-024-00532-3. Epub ahead of print. PMID: 38311658.

Tags: Endocrinology, Estrogen, GAHT, General Internal Medicine, HRT, Med Peds, Publications, Research design, Transgender, Veterans Administration

Related Posts

DDX20 is required for cell-cycle reentry of prospermatogonia and establishment of spermatogonial stem cell pool during testicular development in mice

Zou D, Li K, Su L, Liu J, Lu Y, Huang R, Li M, Mang X, Geng Q, Li P, Tang J, Yu Z, Zhang[...]

Author Correction: Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia

Koeberl D, Schulze A, Sondheimer N, Lipshutz GS, Geberhiwot T, Li L, Saini R, Luo J, Sikirica V, Jin L, Liang M, Leuchars M, Grunewald[...]

Time-to-Event Genome-Wide Association Study for Incident Cardiovascular Disease in People With Type 2 Diabetes

Kwak SH, Hernandez-Cancela RB, DiCorpo DA, Condon DE, Merino J, Wu P, Brody JA, Yao J, Guo X, Ahmadizar F, Meyer M, Sincan M, Mercader[...]